DexCom, Inc.
DXCM
$72.39
-$5.45-7.00%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 12.00% | -1.01% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 12.00% | -1.01% | |||
| Cost of Revenue | 14.31% | 6.04% | |||
| Gross Profit | 10.44% | -5.25% | |||
| SG&A Expenses | 6.85% | -7.91% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 9.78% | -0.48% | |||
| Operating Income | 24.28% | -3.80% | |||
| Income Before Tax | 19.11% | -5.54% | |||
| Income Tax Expenses | 39.25% | -3.39% | |||
| Earnings from Continuing Operations | 12.70% | -6.20% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 12.70% | -6.20% | |||
| EBIT | 24.28% | -3.80% | |||
| EBITDA | 19.01% | -1.33% | |||
| EPS Basic | 13.73% | -5.01% | |||
| Normalized Basic EPS | 20.19% | -4.32% | |||
| EPS Diluted | 13.34% | -4.56% | |||
| Normalized Diluted EPS | 20.13% | -4.01% | |||
| Average Basic Shares Outstanding | -0.91% | -1.25% | |||
| Average Diluted Shares Outstanding | -0.85% | -1.58% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
